Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseTransplantation ConditioningLiver TransplantationBone MarrowTransplantation, AutologousKidney TransplantationBone Marrow CellsWhole-Body IrradiationHematologic NeoplasmsLiving DonorsTreatment OutcomeTransplantation ChimeraRetrospective StudiesTissue DonorsTissue and Organ ProcurementStem Cell TransplantationHistocompatibility TestingMyeloablative AgonistsGraft SurvivalHistocompatibilityLeukemiaBusulfanHematopoietic Stem CellsAnemia, AplasticUnrelated DonorsPeripheral Blood Stem Cell TransplantationRecurrenceBone and BonesLeukemia, Myeloid, AcuteImmunosuppressive AgentsRemission InductionCord Blood Stem Cell TransplantationGraft RejectionGraft vs Tumor EffectHematopoiesisCyclophosphamideSurvival AnalysisHLA AntigensCombined Modality TherapyTransplantation ImmunologyTime FactorsTransplantation, IsogeneicGraft vs Leukemia EffectLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow PurgingHeart TransplantationVidarabineChimerismSurvival RateHematologic DiseasesHepatic Veno-Occlusive DiseaseAcute DiseaseCell TransplantationImmunosuppressionDisease-Free SurvivalMice, Inbred C57BLLymphoma, Non-HodgkinLung TransplantationSiblingsCyclosporineFollow-Up StudiesLymphocyte DepletionT-LymphocytesLymphocyte TransfusionBone Marrow DiseasesTransplantationLeukemia, MyeloidMultiple MyelomaSevere Combined ImmunodeficiencyOrgan TransplantationRadiation ChimeraCytomegalovirus InfectionsDonor SelectionAntineoplastic Combined Chemotherapy ProtocolsAntilymphocyte SerumBone Marrow ExaminationColony-Forming Units AssayAntigens, CD34Islets of Langerhans TransplantationCell DifferentiationMinor Histocompatibility AntigensGraft vs Host ReactionLeukocyte TransfusionPrognosisMelphalanLymphomaHodgkin DiseaseRisk FactorsPancreas TransplantationFlow CytometryChimeraBone Marrow NeoplasmsInfectionBone RemodelingHematopoietic Stem Cell Mobilization